Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 55.82 USD -22.96% Market Closed
Market Cap: 7.7B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one GMED stock under the Base Case scenario is 112.5 USD. Compared to the current market price of 55.82 USD, Globus Medical Inc is Undervalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GMED Relative Value
Base Case
112.5 USD
Undervaluation 50%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3
P/S
P/S
Price to Sales
3
vs History
92
vs Industry
30
Median 3Y
5.2
Median 5Y
6
Industry
2.2
Forward
2.7
More Details
74.5
P/E
P/E
Price to Earnings
74.5
vs History
20
vs Industry
4
Median 3Y
48.6
Median 5Y
49.1
Industry
21.8
Forward
16.2
More Details
14.7
P/OCF
P/OCF
Price to OCF
14.7
vs History
96
vs Industry
19
Median 3Y
29.8
Median 5Y
29.8
Industry
13.5
More Details
18.9
P/FCFE
P/FCFE
Price to FCFE
18.9
vs History
96
vs Industry
18
Median 3Y
45
Median 5Y
43.7
Industry
19.8
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
79
vs Industry
34
Median 3Y
2.7
Median 5Y
3.4
Industry
2.1
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
92
vs Industry
30
Median 3Y
4.7
Median 5Y
5.6
Industry
2.3
Forward
2.4
More Details
4.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.6
vs History
90
vs Industry
35
Median 3Y
7.1
Median 5Y
7.6
Industry
4.8
More Details
14.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.3
vs History
79
vs Industry
17
Median 3Y
20.7
Median 5Y
22.8
Industry
11.5
Forward
7.6
More Details
30.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
30.9
vs History
34
vs Industry
9
Median 3Y
35
Median 5Y
35.3
Industry
15.7
Forward
11
More Details
13
EV/OCF
EV/OCF
Enterprise Value to OCF
13
vs History
96
vs Industry
21
Median 3Y
28.3
Median 5Y
27.8
Industry
13.5
More Details
16.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
16.7
vs History
96
vs Industry
19
Median 3Y
43.4
Median 5Y
41.2
Industry
17.6
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
76
vs Industry
34
Median 3Y
2.5
Median 5Y
3.6
Industry
1.8
More Details

Multiples Across Competitors

GMED Competitors Multiples
Globus Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Globus Medical Inc
NYSE:GMED
7.7B USD 3 74.5 14.3 30.9
US
Abbott Laboratories
NYSE:ABT
230.7B USD 5.4 17.1 22.2 31.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.1B USD 21.9 77.2 61.6 74.2
US
Boston Scientific Corp
NYSE:BSX
152.2B USD 8.7 74.8 35.3 49.1
US
Stryker Corp
NYSE:SYK
145.5B USD 6.3 50.9 25.2 30.4
IE
Medtronic PLC
NYSE:MDT
107.1B USD 3.2 25.1 13.5 19.1
DE
Siemens Healthineers AG
XETRA:SHL
52.7B EUR 2.3 26.5 15.4 21.9
US
Becton Dickinson and Co
NYSE:BDX
47.9B USD 2.3 31.6 12.7 23.8
US
Edwards Lifesciences Corp
NYSE:EW
43.4B USD 7.8 10.4 23.7 26.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.7B USD 10.1 44.4 31.5 35.2
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
271.6B CNY 7.6 24.4 21.3 21.3

See Also

Summary
GMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
GMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GMED stock valuation using valuation multiples.
Wall Street Estimates
GMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 253,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.